PP
Schedule 13G filing
Pertento Partners LLP disclosed a 5.2% stake in Cellebrite DI Ltd. (CLBT)
Pertento Partners LLP reported owning 5.2% of Cellebrite DI Ltd. (CLBT) (13,164,696 shares) in a Schedule 13G filed Oct 9, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More CLBT insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.